ACADIA Pharmaceuticals Inc.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| NORLIGHT NCT07284667 |
P2 | Recruiting | Major Depressive Disorder (MDD); Depressive Disorder, Treatment-Resistant | 153 | 2027-08 |
| ACP-204 NCT06159673 |
P2/3 | Recruiting | Alzheimer's Disease Psychosis | 1074 | 2028-01 |
| ACP-204 NCT07029581 |
P2 | Recruiting | Lewy Body Dementia Psychosis | 180 | 2028-02 |
| ACP-204 NCT07095465 |
P3 | Recruiting | Lewy Body Dementia Psychosis | 126 | 2029-02 |
| ACP-204 NCT06194799 |
P3 | Enrolling by invitation | Alzheimer's Disease Psychosis | 752 | 2029-04 |